BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11030824)

  • 1. Transformation of cell type in uveal melanomas: a quantitative histologic analysis.
    Bechrakis NE; Sehu KW; Lee WR; Damato BE; Foerster MH
    Arch Ophthalmol; 2000 Oct; 118(10):1406-12. PubMed ID: 11030824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncontiguous tumor recurrence of posterior uveal melanoma after transscleral local resection.
    Kim JW; Damato BE; Hiscott P
    Arch Ophthalmol; 2002 Dec; 120(12):1659-64. PubMed ID: 12470139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Cytologic Features of Uveal Melanoma.
    Medina CA; Biscotti CV; Singh N; Singh AD
    Ophthalmology; 2015 Aug; 122(8):1580-4. PubMed ID: 26012864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings.
    Shields CL; Shields JA; Karlsson U; Menduke H; Brady LW
    Ophthalmology; 1990 Dec; 97(12):1665-70. PubMed ID: 2087297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of morphometric features and the callender classification in uveal melanomas.
    Coleman K; Baak JP; van Diest PJ; Mullaney J
    Ophthalmology; 1996 Oct; 103(10):1634-41. PubMed ID: 8874437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of PCNA and Ki-67 in posterior uveal melanomas in adults.
    Proniewska-Skretek E; Dziecioł J; Zalewska R; Mariak Z
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():79-81. PubMed ID: 15638382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of inflammatory cells in uveal melanoma after prior irradiation.
    Vu TH; Bronkhorst IH; Versluis M; Marinkovic M; van Duinen SG; Vrolijk J; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):360-9. PubMed ID: 23211827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two discrete uveal melanomas in a child with ocular melanocytosis.
    Shields CL; Eagle RC; Ip MS; Marr BP; Shields JA
    Retina; 2006; 26(6):684-7. PubMed ID: 16829813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study.
    Folberg R; Pe'er J; Gruman LM; Woolson RF; Jeng G; Montague PR; Moninger TO; Yi H; Moore KC
    Hum Pathol; 1992 Nov; 23(11):1298-305. PubMed ID: 1427757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection.
    Suesskind D; Scheiderbauer J; Buchgeister M; Partsch M; Budach W; Bartz-Schmidt KU; Ritz R; Grisanti S; Paulsen F
    JAMA Ophthalmol; 2013 May; 131(5):630-7. PubMed ID: 23494018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis.
    McLean IW; Foster WD; Zimmerman LE
    Hum Pathol; 1982 Feb; 13(2):123-32. PubMed ID: 7076200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical assessment of mitotic count in uveal melanoma.
    Angi M; Damato B; Kalirai H; Dodson A; Taktak A; Coupland SE
    Acta Ophthalmol; 2011 Mar; 89(2):e155-60. PubMed ID: 19900200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iris melanomas.
    Geisse LJ; Robertson DM
    Am J Ophthalmol; 1985 Jun; 99(6):638-48. PubMed ID: 4014387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term prognosis of 29 patients with uveal malignant melanoma who were operated on by local resection or enucleation].
    Fujishiro T; Kojima T
    Nippon Ganka Gakkai Zasshi; 2008 Oct; 112(10):847-54. PubMed ID: 18949909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of melanoma cell type in uveal melanoma following treatment failure.
    Char DH; Miller T; Crawford JB
    Am J Ophthalmol; 2004 Oct; 138(4):543-6. PubMed ID: 15488778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology of proton beam-irradiated vs enucleated uveal melanomas.
    Saornil MA; Egan KM; Gragoudas ES; Seddon JM; Walsh SM; Albert DM
    Arch Ophthalmol; 1992 Aug; 110(8):1112-8. PubMed ID: 1323252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology.
    McLean IW; Foster WD; Zimmerman LE; Gamel JW
    Am J Ophthalmol; 1983 Oct; 96(4):502-9. PubMed ID: 6624832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltrative T regulatory cells in enucleated uveal melanomas.
    Lagouros E; Salomao D; Thorland E; Hodge DO; Vile R; Pulido JS
    Trans Am Ophthalmol Soc; 2009 Dec; 107():223-8. PubMed ID: 20126498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.